ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Prism Medico & Pharmacy's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹-9.63 Mil.
Prism Medico & Pharmacy's average Total Assets over the quarter that ended in Mar. 2026 was ₹156.11 Mil. Therefore, Prism Medico & Pharmacy's annualized ROA % for the quarter that ended in Mar. 2026 was -6.17%.
The historical rank and industry rank for Prism Medico & Pharmacy's ROA % or its related term are showing as below:
BOM:512217'
s ROA % Range Over the Past 10 Years
Min: -2.17 Med: -0.29 Max: 2.47
Current: 2.04
During the past 13 years, Prism Medico & Pharmacy's highest ROA % was 2.47%. The lowest was -2.17%. And the median was -0.29%.
BOM:512217's ROA % is ranked worse than 58.71% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 3.24
vs BOM:512217: 2.04
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Prism Medico & Pharmacy's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's ROA % distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Prism Medico & Pharmacy (BOM:512217) has a ROA % of -6.17% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Prism Medico & Pharmacy and its competitors. According to the industry distribution chart, Prism Medico & Pharmacy ranks #1166 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 58.7%.
Is Prism Medico & Pharmacy's ROA % too high?
Prism Medico & Pharmacy's current ROA % is -6.17%. Based on the distribution chart, Prism Medico & Pharmacy ranks #1166 out of 1986 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's ROA % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #1166 out of 1986 companies for ROA %. This places Prism Medico & Pharmacy in the lower half of its industry. The industry median ROA % is 3.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.24, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current ROA % is -6.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.40, compared to a current price of ₹28.80 — trading 5.1% above its estimated fair value. The current ROA % is -6.17%. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current ROA % is -6.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹28.80 is trading 5.1% above its estimated GF Value™ of ₹27.40.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
ROA %: -6.17%
GF Value™: ₹27.40 vs. price of ₹28.80 (5.1% above fair value)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
53GF Score
Get the complete analysis for BOM:512217
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 
